Relative Strength Index

Search documents
After Plunging 8.8% in 4 Weeks, Here's Why the Trend Might Reverse for Cervecerias Unidas (CCU)
ZACKS· 2025-06-10 14:35
Cervecerias Unidas (CCU) has been on a downward spiral lately with significant selling pressure. After declining 8.8% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum ...
Down 18.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Banco Macro (BMA)
ZACKS· 2025-06-10 14:35
A downtrend has been apparent in Banco Macro (BMA) lately with too much selling pressure. The stock has declined 18.2% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. T ...
X @Investopedia
Investopedia· 2025-06-09 02:00
The benchmark index broke out from a pennant pattern last week, indicating a continuation of its recent move higher, while the relative strength index confirms bullish momentum. Monitor these key price levels https://t.co/9SgjVTZ1uT ...
3 Oversold Stocks Flashing Bullish Reversal Signals
MarketBeat· 2025-06-07 13:47
Group 1: Copart Inc. (NASDAQ: CPRT) - Copart's stock has experienced a significant decline, dropping over 21% from its all-time highs, with the Relative Strength Index (RSI) falling to 21, indicating it is deeply oversold and may be poised for a bounce [3][4]. - The recent plunge in Copart's stock price was attributed to an underwhelming earnings report, despite the company achieving its highest-ever revenue, which led to concerns that expectations had outpaced fundamentals [4][5]. - Analysts maintain a Neutral rating on Copart, with a price target of $55, suggesting that the stock is currently trading below its fair value, presenting an attractive risk/reward scenario [5]. Group 2: Cooper Companies Inc. (NASDAQ: COO) - Cooper Companies' stock has been on a downward trend, hitting multi-month lows with an RSI in the low 20s, indicating oversold conditions [7]. - Following a strong earnings report that exceeded expectations and reaffirmed full-year guidance of 10-15% EPS growth, the stock saw a nearly 6% increase in one day, with the RSI beginning to rise [8][9]. - Analysts have a 12-month price forecast of $100.38 for Cooper Companies, indicating a potential upside of 38.77% from the current price of $72.33 [6]. Group 3: UnitedHealth Group Inc. (NYSE: UNH) - UnitedHealth's stock has declined over 50% from its April highs due to disappointing earnings and negative market sentiment [10]. - Despite bearish trends, the stock has shown signs of stabilization, with the RSI remaining below 30 and a bullish crossover in the MACD, indicating potential for recovery [11]. - Analysts have reiterated positive ratings, with KeyCorp maintaining an Overweight rating and a price target of $400, suggesting a potential upside of over 35% from current levels [12].
Analyst sets date when Tesla stock will hit $600 after Trump v. Musk feud
Finbold· 2025-06-07 12:02
Core Viewpoint - A trading analyst maintains a bullish outlook on Tesla, setting a price target of $600 despite recent tensions between CEO Elon Musk and President Donald Trump [1][10]. Group 1: Market Reaction and Stock Performance - Tesla's market cap decreased by $150 billion on June 5, but the stock rebounded over 3% to close at $295 on June 6 [2]. - The recent dip in Tesla's stock is viewed as a short-term pullback within a broader bullish trend [4]. Group 2: Technical Analysis - Tesla is currently within a long-term upward channel that began after the stock's low in January 2023, with a significant support level identified at the 0.236 Fibonacci retracement [5]. - The current downturn is interpreted as the early stage of a bull flag, suggesting a potential breakout in the near future [6]. - A price target of $600 aligns with the upper boundary of the channel and the 1.0 Fibonacci extension, which could be reached by early November 2025 if the bullish trend persists [7]. Group 3: Upcoming Events and Strategic Focus - Attention is shifting towards Tesla's upcoming robotaxi unveiling on June 12, which is considered crucial for the company's push for unsupervised autonomous driving approval [8]. - The public feud between Musk and Trump is expected to diminish as the robotaxi launch approaches, with analysts expressing optimism about Tesla's stock prospects [10]. Group 4: Broader Market Sentiment - Wall Street remains optimistic about Tesla, with Morgan Stanley reaffirming a long-term price target of $1,000, contingent on successful expansion into drones and urban air mobility [10][11].
Down 10.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Interpublic (IPG)
ZACKS· 2025-06-06 14:36
Core Viewpoint - Interpublic Group (IPG) has experienced a significant decline of 10.2% over the past four weeks, but it is now in oversold territory, indicating a potential for a trend reversal as analysts expect better earnings than previously predicted [1]. Group 1: Stock Performance and Technical Indicators - IPG's Relative Strength Index (RSI) reading is at 29.14, suggesting that the heavy selling pressure may be exhausting, which could lead to a rebound in stock price [5]. - The RSI is a momentum oscillator that helps identify whether a stock is oversold, typically when the reading falls below 30 [2][3]. Group 2: Analyst Sentiment and Earnings Estimates - There is a strong consensus among sell-side analysts that IPG will report better earnings, with a 0.1% increase in the consensus EPS estimate over the last 30 days [7]. - IPG holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a potential turnaround [8].
Analyst sets date when Meta stock will hit $770
Finbold· 2025-06-04 14:42
Technical indicators suggest Meta Platforms (NASDAQ: META) stock could hit $770 in the coming weeks.To reach this level, the stock would need to rally about 13% from its current price of around $680. This bullish outlook follows Meta’s impressive run in recent weeks, with shares gaining nearly 15% over the past month.META one-month stock price chart. Source: FinboldMeta’s path to $770From a technical standpoint, analysis by TradingShot indicated that Meta has flashed its strongest short-term bullish signal ...
Gauzy Ltd. (GAUZ) Loses 19.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-06-04 14:36
A downtrend has been apparent in Gauzy Ltd. (GAUZ) lately with too much selling pressure. The stock has declined 19.7% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spot ...
Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros (OMER)
ZACKS· 2025-06-03 14:36
Omeros (OMER) has been on a downward spiral lately with significant selling pressure. After declining 54.8% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is ov ...
Down 36.7% in 4 Weeks, Here's Why Summit Therapeutics (SMMT) Looks Ripe for a Turnaround
ZACKS· 2025-06-03 14:36
A downtrend has been apparent in Summit Therapeutics PLC (SMMT) lately with too much selling pressure. The stock has declined 36.7% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical ind ...